Latest filing published 07 Jul 2022 for Frequency Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Wendy S. Arnold: trading record in brief
This profile gathers the share dealings of Wendy S. Arnold in Korro Bio, Inc., where the filings describe the role as senior executive. In total, 8 filings cover trades dated from 14 February 2022 to 6 July 2022.
Every open-market trade on record is a sale: 6 sales worth €29k. Outside the open market, there are 2 option exercises.
On 7 July 2022 came the latest disclosure, an open-market sale for €8,413 in Korro Bio, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Wendy S. Arnold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 sharesCommon StockSEC:0001127602-22-019047:0
- 1,209 shares@ US$3.87450.0% of flowCommon StockSEC:0001127602-22-006307:0
- 1,057 shares@ US$4.42950.0% of flowCommon StockSEC:0001127602-22-005743:0
- 15,000 sharesCommon StockSEC:0001127602-22-005319:0
4 of 4 declarations
